


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+0.64%
-3.14%
-1.40%
WVE
Wave Life Sciences
$16.56
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Trading below its fair value

Outperform the market
Technical Indicators

MACD below signal line
WVE Price Performance
$7.15 (+131.61%)
$6.89 (+140.35%)
$8.39 (+97.38%)
$12.9 (+28.37%)
WVE has Medium risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

High volatilty

WVE overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a weak earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
WVE Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
WVE Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is WVE current stock price?
What are WVE stock strengths?
What is WVE Risk Level?
What is WVE market cap and volume?
What is WVE current Stock IQ?
Should I buy WVE stock right now?
Is WVE a Strong Buy right now?
What does a 'Strong Buy' rating mean for WVE?
What does a 'Strong Sell' rating mean for WVE?
What factors influence WVE's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.64%
-3.14%
-1.40%
WVE
Wave Life Sciences
Current Price
$16.56
Stock Insights
Strengths

Upgraded on attractively valued

Earnings are forecast to grow

Trading below its fair value

Outperform the market
Technical Indicators

MACD below signal line

WVE Price Performance
$7.15 (+131.61%)
$6.89 (+140.35%)
$8.39 (+97.38%)
$12.9 (+28.37%)
WVE Analysts Opinion
WVE Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Reported a weak earnings

Below analyst estimate
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow

Trading below its fair value

Outperform the market
![]()
WVE Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
WVE Street Sentiment is extremely bullish and have positive views on the near-term outlook
WVE has Medium risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

High volatilty

Average key support and resistance price levels
WVE Stock IQ
WVE Latest Analysis
Wedbush Maintains Wave Life Sciences (WVE) Outperform Recommendation. Fintel reports that on December 12 2025 Wedbush maintained coverage of Wave Life Sciences (NasdaqGM:WVE) with a Outperform recommendation. Analyst Price Forecast Suggests 21.41% Upside
Fri Dec 12, 2025
WVE Crosses Above Average Analyst Target. In recent trading shares of Wave Life Sciences Ltd (Symbol: WVE) have crossed above the average analyst 12-month target price of $19.80 changing hands for $21.31/share. When a stock reaches the target an analyst has set the analyst logically has two ways to react: downgrade o
Wed Dec 10, 2025
Wave Life Sciences prices upsized $350M stock offering.
Wed Dec 10, 2025
Wave Life Sciences: 200% Rally On 1% Weight Loss Feels Bloated.
Wed Dec 10, 2025
Wells Fargo Maintains Wave Life Sciences (WVE) Overweight Recommendation. Fintel reports that on December 9 2025 Wells Fargo maintained coverage of Wave Life Sciences (NasdaqGM:WVE) with a Overweight recommendation. Analyst Price Forecast Suggests 9.81% Upside
Wed Dec 10, 2025
Canaccord Genuity Maintains Wave Life Sciences (WVE) Buy Recommendation. Fintel reports that on December 9 2025 Canaccord Genuity maintained coverage of Wave Life Sciences (NasdaqGM:WVE) with a Buy recommendation. Analyst Price Forecast Suggests 9.81% Upside
Wed Dec 10, 2025
Citigroup Maintains Wave Life Sciences (WVE) Buy Recommendation. Fintel reports that on December 9 2025 Citigroup maintained coverage of Wave Life Sciences (NasdaqGM:WVE) with a Buy recommendation. Analyst Price Forecast Suggests 9.81% Upside
Wed Dec 10, 2025
Why Wave Life Sciences Stock Crushed it Again Today. Key PointsIt wasnt hard to be optimistic about the biotechs future given its excellent news from the lab on Monday.
Wed Dec 10, 2025
Cantor Fitzgerald Maintains Wave Life Sciences (WVE) Overweight Recommendation. Fintel reports that on December 9 2025 Cantor Fitzgerald maintained coverage of Wave Life Sciences (NasdaqGM:WVE) with a Overweight recommendation. Analyst Price Forecast Suggests 9.81% Upside
Tue Dec 9, 2025
Clear Street Maintains Wave Life Sciences (WVE) Buy Recommendation. Fintel reports that on December 9 2025 Clear Street maintained coverage of Wave Life Sciences (NasdaqGM:WVE) with a Buy recommendation. Analyst Price Forecast Suggests 9.81% Upside
Tue Dec 9, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.